Corient Private Wealth
OCGN icon

Corient Private Wealth’s Ocugen OCGN Stock Holding History

Corient Private Wealth’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-900,000
Closed -$1.22M – 2947
2025
Q4 		$1.22M Hold
900,000
– – ﹤0.01% 1402
2025
Q3 		$1.47M Sell
900,000
-100
-0% -$111 ﹤0.01% 1230
2025
Q2 		$873K Hold
900,100
– – ﹤0.01% 1429
2025
Q1 		$636K Hold
900,100
– – ﹤0.01% 1486
2024
Q4 		$725K Sell
900,100
-30
-0% -$27 ﹤0.01% 1449
2024
Q3 		$893K Hold
900,130
– – ﹤0.01% 1452
2024
Q2 		$1.4M Buy
+900,130
New +$1.4M ﹤0.01% 1192

Other funds holding OCGN

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Corient Private Wealth's OCGN Position: Q1 2026 in Review

Corient Private Wealth sold out of Ocugen (OCGN) in Q1 2026, closing a stake of 900,000 shares — an estimated $1.22M sold.

Corient Private Wealth first reported a position in OCGN in Q2 2024 and held it in 7 quarters. The position peaked at $1.47M in Q3 2025. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

  • Corient Private Wealth reported no remaining Ocugen position as of Q1 2026 after selling out during the quarter.
  • Corient Private Wealth sold 900,000 Ocugen shares in Q1 2026, an estimated $1.22M.
  • Corient Private Wealth first reported a position in Ocugen in Q2 2024 and held it in 7 quarters.
  • Corient Private Wealth's Ocugen position peaked at $1.47M in Q3 2025.
  • 137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.